From the first launch to ongoing market access operational execution, IntegriChain solves some of the most complex and pressing challenges associated with drug commercialization. We deliver pharma’s only comprehensive data, consulting, and business process platform for market access departments, providing the strategy, data, applications, and infrastructure for therapy commercialization.
Solutions overview
IntegriChain delivers the pharmaceutical industry’s largest and only data and business process platform for therapy commercialization and access. Manufacturers rely on our analytics, applications, and managed services to power their operations and harness the value of their channel, patient and payer data.
View all products
IntegriChain provides a complete set of professional services for commercialization and market access execution–from life science strategy and operational consulting to implementation, integration, migrations, and analytics.
Services overview
We help all stakeholders in the pharmaceutical industry drive access with our relentless focus on unifying all of the critical business functions for therapy commercialization and access – contracts & pricing, gross-to-net, channel, and patient services – to unlock strategic payer, provider, pharmacy and patient access insights.
Learn more about our company
Learn more about joining our growing IntegriChain team of data scientists, market access experts, analysts, and consulting professionals – our culture, our purpose, our teams in the US and Pune. Check out our careers or keep in touch for future opportunities.
Careers overview
”We have worked with IntegriChain since our product launch one year ago. IntegriChain has operated as an extension of both our Finance and Market Access teams and has become a trusted advisor.”
VP, Contract & Pricing
Once a therapy is in market, pharma manufacturers of in-line products within the commercial life sciences sector need to continually assess their pharmaceutical operations and validate the estimates, forecasts, and assumptions that were made during launch. By using actual contract and pricing, channel, and patient data, manufacturers can determine the effectiveness of their payer mix, channel strategy, patient conversion, and distribution flow. They can also assess whether the gross-to-net model created at launch really takes into account all/any channel inventory, contracting, patient support costs, fees, rebates, chargebacks and other sales adjustments.
IntegriChain has worked with hundreds of commercial life sciences market access pharma teams to help them achieve operational excellence, equipping them with the tools and resources needed to streamline and adjust their strategy to manage their products.
Contact Our Market Access Pharma Team
Seamlessly evolve from launch to inline product management
Gain a clear line of sight into financial performance
Utilize actual data to adjust channel and distribution strategy
Assess and benchmark patient conversion rates
Leverage inventory analytics to achieve downstream visibility
Adjust channel and distribution strategy with accurate data
Reduce manual effort required to complete financial reporting
Improve specialty pharmacy engagement and performance
Download the Whitepaper: The Case for Managed Services.
Chargeback data reconciliation and analytics services across GPO/IDN provider and federal contracts
Managed Care, Part D, Tricare, Medicaid rebate adjudication and contract compliance validations
Accurate management of adjustments and disputes with payers and states
State pricing transparency administration and policy and procedure updates
Multiple managed services delivery models
Automated process to adjudicate Medicaid claims, rejecting invalid claims and eliminating over-payments
Executing a best-in-class market access strategy for pharma in-line products requires a modern, adaptable infrastructure.This infrastructure covers everything from hardware and cloud connectivity, to applications and the myriad of data inputs necessary to satisfy the needs of finance, contracts and pricing, trade and channel, patient services, and field reimbursement teams.
By leveraging market access consulting, tailored analytics, and service delivery from a team of experts, pharmaceutical manufacturers can focus on driving the business, rather than be mired in back office and administrative processing.
Chargeback processing and credit management
Contract or product system set up and administration
Contract compliance validations
Policy and procedure updates
State pricing transparency administration
Improve Your Pharmaceutical Operations
Uncover how IntegriChain helped an emerging rare disease company prepare for operational success with a standard operating blueprint that could be adjusted for the needs of each therapy.
Download the Case Study
Based on more than 15 years of experience with more than 250 pharmaceutical manufacturers, here are the 10 most common challenges facing Market Access operations, broken down into three critical categories.
Read the Post
